|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
06-25-2010, 10:46 PM
|
|||
|
|||
Cyclosporine treatment develops higher de novo cancer risk in liver transplant patien
Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Organ-Rejection Drug Linked to Higher Cancer Risk After Liver Transplant | cancerfr | Liver Cancer | 0 | 06-29-2010 11:22 AM |
| Higher cancer rates found in liver transplant patients receiving cyclosporine for imm | cancerfr | Liver Cancer | 0 | 06-29-2010 11:22 AM |
| Higher Cancer Rates Found In Liver Transplant Patients Receiving Cyclosporine For Imm | cancerfr | Liver Cancer | 0 | 06-25-2010 10:46 PM |
Linear Mode
